New molecular mechanisms of growth hormone insensitivity

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
T EdouardM Tauber

Abstract

Growth hormone (GH), secreted by the anterior pituitary into the circulation, binds to membrane receptors in target tissues to stimulate body growth; most of its effects is mediated by the insulin-like growth factor 1 (IGF-1). In addition to promoting growth, GH has important metabolic actions. The syndrome of GH insensitivity (GHI) was first identified in 1966 by Laron et al. in three children with clinical phenotype characteristic of growth hormone deficiency but associated with elevated serum concentration of GH. Direct evidence of a GH receptor (GHR) abnormality was provided in 1989. More recently, molecular abnormalities in the postreceptor signalling mechanism were found. Mutations of signal transducer and activator of transcription 5b (Stat5b) were reported in patients with growth retardation and primary immunodeficiency. Mutations of the tyrosin phosphatase Shp2 were identified in patients affected by Noonan syndrome characterized by short stature, cardiopathy and increased risk of leukaemia. The unmasking of the molecular bases for these defects will contribute greatly to our future understanding of both normal and aberrant growth. Moreover, this knowledge should bring insight on cancerogenesis or immunodeficiency caus...Continue Reading

References

Aug 1, 1991·Endocrine Reviews·P A KellyM Edery
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P J GodowskiW I Wood
Dec 1, 1988·European Journal of Pediatrics·M B RankeJ R Bierich
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·W H Daughaday, B Trivedi
Mar 10, 1998·Cell·P HofS E Shoelson
Dec 22, 1999·Journal of Pediatric Hematology/oncology·K ChoongA Zipursky
Oct 18, 2002·Human Genetics·Andra IonSteve Jeffery
Nov 26, 2002·Endocrinology·Sung-Oh KimStuart J Frank
Jun 27, 2003·Trends in Biochemical Sciences·Benjamin G NeelLily Pao
Sep 19, 2003·The New England Journal of Medicine·Eric M KofoedRon G Rosenfeld
Dec 6, 2003·The New England Journal of Medicine·M Jennifer AbuzzahabUNKNOWN Intrauterine Growth Retardation (IUGR) Study Group
Mar 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Zvi Laron
Dec 3, 2004·The Journal of Biological Chemistry·Alexandra MontagnerPatrick Raynal
Dec 17, 2004·Molecular and Cellular Biology·Jennifer E RowlandMichael J Waters
Apr 14, 2005·The Journal of Clinical Endocrinology and Metabolism·Vivian HwaRon G Rosenfeld
Jun 30, 2005·The Journal of Clinical Endocrinology and Metabolism·G BinderN E Wittekindt
Jul 1, 2005·The Journal of Biological Chemistry·Heike KeilhackBenjamin G Neel
Sep 20, 2005·Nature Genetics·Yoko AokiYoichi Matsubara
Nov 3, 2005·The Journal of Clinical Endocrinology and Metabolism·Jean-Marie LimalYves Le Bouc
Dec 6, 2005·American Journal of Medical Genetics. Part a·Karen W GrippKatia Sol-Church
Dec 17, 2005·American Journal of Human Genetics·Marco TartagliaBruce D Gelb
Dec 27, 2005·The Journal of Biological Chemistry·Maria I KontaridisBenjamin G Neel
May 24, 2006·Molecular Pharmacology·Liwei ChenJie Wu
Jun 22, 2006·The Journal of Clinical Endocrinology and Metabolism·Solrun VidarsdottirJohannes A Romijn
Aug 4, 2006·The FEBS Journal·Andrea P Rojas-GilBessie E Spiliotis

❮ Previous
Next ❯

Citations

Oct 29, 2008·Annales d'endocrinologie·F CastinettiT Brue
Nov 14, 2015·La Presse médicale·Hanane Latrech, Michel Polak

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

© 2021 Meta ULC. All rights reserved